Ppargc1B — Pparg Coactivator 1 Beta is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The PPARGC1B (PPARG Coactivator 1 Beta) gene, also known as PGC-1β (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Beta), encodes a transcriptional coactivator critical for mitochondrial biogenesis, energy metabolism, and cellular stress responses. It plays important roles in neurodegenerative diseases. [@handschin2007]
PGC-1β is a transcriptional coactivator that regulates genes involved in energy metabolism:
...
PPARGC1B — PPARG Coactivator 1 Beta
Introduction
Ppargc1B — Pparg Coactivator 1 Beta is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The PPARGC1B (PPARG Coactivator 1 Beta) gene, also known as PGC-1β (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Beta), encodes a transcriptional coactivator critical for mitochondrial biogenesis, energy metabolism, and cellular stress responses. It plays important roles in neurodegenerative diseases. [@handschin2007]
Lin J, et al. (2004). "Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice." Cell. [DOI:10.1016/j.cell.2004.06.016](https://doi.org/10.1016/j.cell.2004.06.016)
Handschin C, Spiegelman BM. (2006). "Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism." Endocr Rev. [DOI:10.1210/er.2006-0037](https://doi.org/10.1210/er.2006-0037)
St-Pierre J, et al. (2006). "Suppression of [reactive oxygen species](/entities/reactive-oxygen-species) and neurodegeneration by the PGC-1 transcriptional coactivators." Cell. [DOI:10.1016/j.cell.2006.09.024](https://doi.org/10.1016/j.cell.2006.09.024)
Luo C, et al. (2016). "PGC-1α in neurodegeneration: a therapeutic target?" Neurobiol Aging. [DOI:10.1016/j.neurobiolaging.2016.02.019](https://doi.org/10.1016/j.neurobiolaging.2016.02.019)
Yang X, et al. (2020). "PPARGC1B deletion induces dopaminergic neuron loss in mice." Neuropharmacology. [DOI:10.1016/j.neuropharm.2020.108044](https://doi.org/10.1016/j.neuropharm.2020.108044)
Background
The study of Ppargc1B — Pparg Coactivator 1 Beta has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.